{"DataElement":{"publicId":"3119329","version":"1","preferredName":"Melanoma Pathological N Stage","preferredDefinition":"Code to represent the extent of melanoma in the regional lymph nodes (N) based on staging guidelines from the AJCC edition 7.0.","longName":"2192169v1.0:3119319v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2192169","version":"1","preferredName":"Melanoma Tumor Pathologic N Stage","preferredDefinition":"information related to the pathologic N stage of a melanoma tumor.","longName":"MELANOMA_TUMOR_P_N","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206800","version":"1","preferredName":"Melanoma Neoplasm","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes that contain melanin.  Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma.  Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi.  Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system.  Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain. -- 2004:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C3224:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-04EC-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2428379","version":"1","preferredName":"Pathologic N Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C25610:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-084E-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E8EDF600-CF90-5FAE-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-11-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Updated to use Property based on NCIt concepts","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3119319","version":"1","preferredName":"Melanoma Pathological N Stage","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes that contain melanin.  Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma.  Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi.  Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system.  Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain. -- 2004_An examination that is performed to determine the extent of the spread of cancer based on histopathologic examination of one or more pathology specimens.  Pathologic staging uses evidence acquired during the process of clinical staging, supplemented by histopathologic examination of surgical specimens._One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"3119319v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N3","valueDescription":"4 or more metastatic nodes, or matted nodes, or in transit met(s)/satellite(s) with metastatic node(s)","ValueMeaning":{"publicId":"3119320","version":"1","preferredName":"4 or more metastatic nodes, or matted nodes, or in transit met(s)/satellite(s) with metastatic node(s)","longName":"3119320","preferredDefinition":"4 or more metastatic nodes, or matted nodes, or in transit met(s)/satellite(s) with metastatic node(s)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-89E5-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-89FE-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"},{"value":"N2c","valueDescription":"2 - 3 nodes in transit met(s)/satellite(s) without metastatic nodes","ValueMeaning":{"publicId":"3119321","version":"1","preferredName":"2 - 3 nodes in transit met(s)/satellite(s) without metastatic nodes","longName":"3119321","preferredDefinition":"2 - 3 nodes in transit met(s)/satellite(s) without metastatic nodes","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-8A08-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-8A21-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"},{"value":"N2b","valueDescription":"2 - 3 nodes with macrometastasis","ValueMeaning":{"publicId":"3119322","version":"1","preferredName":"2 - 3 nodes with macrometastasis","longName":"3119322","preferredDefinition":"2 - 3 nodes with macrometastasis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-8A2B-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-8A44-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"},{"value":"N2a","valueDescription":"2 - 3 nodes with micrometastasis","ValueMeaning":{"publicId":"3119323","version":"1","preferredName":"2 - 3 nodes with micrometastasis","longName":"3119323","preferredDefinition":"2 - 3 nodes with micrometastasis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-8A4E-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-8A67-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"},{"value":"N2","valueDescription":"2 - 3 nodes","ValueMeaning":{"publicId":"3119324","version":"1","preferredName":"2 - 3 nodes","longName":"3119324","preferredDefinition":"2 - 3 nodes","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-8A71-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-8A8A-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"},{"value":"N1b","valueDescription":"One node with macrometastasis","ValueMeaning":{"publicId":"3119325","version":"1","preferredName":"One node with macrometastasis","longName":"3119325","preferredDefinition":"One node with macrometastasis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-8A94-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-8AAD-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"},{"value":"N1a","valueDescription":"One node with micrometastasis","ValueMeaning":{"publicId":"3119326","version":"1","preferredName":"One node with micrometastasis","longName":"3119326","preferredDefinition":"One node with micrometastasis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-8AB7-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-8AD0-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"},{"value":"N1","valueDescription":"One node","ValueMeaning":{"publicId":"3119327","version":"1","preferredName":"One node","longName":"3119327","preferredDefinition":"One node","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-8ADA-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-8AF3-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"},{"value":"N0","valueDescription":"N0 Stage Finding","ValueMeaning":{"publicId":"2580833","version":"1","preferredName":"N0 Stage Finding","longName":"2580833","preferredDefinition":"No evidence of regional lymph node metastasis, in accordance with TNM classification system guidelines. (from AJCC 6th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N0 TNM Finding","conceptCode":"C48705","definition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-08CE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-13","modifiedBy":"ONEDATA","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-8AFD-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"},{"value":"NX","valueDescription":"NX Stage Finding","ValueMeaning":{"publicId":"2580837","version":"1","preferredName":"NX Stage Finding","longName":"2580837","preferredDefinition":"Status of regional lymph nodes cannot be assessed in accordance with TNM classification system guidelines. (from AJCC 6th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NX TNM Finding","conceptCode":"C48718","definition":"A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-08D2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-13","modifiedBy":"ONEDATA","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-8B07-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3119318","version":"1","preferredName":"Melanoma Pathological Staging N Stage Stage","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes that contain melanin.  Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma.  Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi.  Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system.  Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain. -- 2004:An examination that is performed to determine the extent of the spread of cancer based on histopathologic examination of one or more pathology specimens.  Pathologic staging uses evidence acquired during the process of clinical staging, supplemented by histopathologic examination of surgical specimens.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C3224:C28257:C25580:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Pathological Staging","conceptCode":"C28257","definition":"An examination that is performed to determine the extent of the spread of cancer based on histopathologic examination of one or more pathology specimens. Pathologic staging uses evidence acquired during the process of clinical staging, supplemented by histopathologic examination of surgical specimens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-89BE-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC:American Joint Committee on Cancer Cancer Staging Manual, 7th Ed., 2009","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-89CF-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"REEVESD","dateModified":"2010-07-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"TCGA Comment","type":"COMMENT","description":"Values of 'Not Otherwise Specified' or 'NOS' may be included in stage values. ","url":null,"context":"NCIP"},{"name":"Pathologic N Stage","type":"Preferred Question Text","description":"Pathologic N Stage","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-8B11-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"TSESU","dateModified":"2018-07-17","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 7/2010","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}